Other News To Note

• Cell Therapeutics Inc., of Seattle, said that it filed with the secretary of state for the State of Washington an amendment to its amended and restated articles of incorporation to implement a 1-for-5 reverse stock. CTI's total number of authorized shares will be decreased from 384,999,999 shares to 76,999,999 shares.